HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A.

Abstract
Druggable proteins required for B lymphocyte survival and immune responses are an emerging source of new treatments for autoimmunity and lymphoid malignancy. In this study, we show that mice with an inactivating mutation in the intramembrane protease signal peptide peptidase-like 2A (SPPL2A) unexpectedly exhibit profound humoral immunodeficiency and lack mature B cell subsets, mirroring deficiency of the cytokine B cell-activating factor (BAFF). Accumulation of Sppl2a-deficient B cells was rescued by overexpression of the BAFF-induced survival protein B cell lymphoma 2 (BCL2) but not BAFF and was distinguished by low surface BAFF receptor and IgM and IgD B cell receptors. CD8-negative dendritic cells were also greatly decreased. SPPL2A deficiency blocked the proteolytic processing of CD74 MHC II invariant chain in both cell types, causing dramatic build-up of the p8 product of Cathepsin S and interfering with earlier steps in CD74 endosomal retention and processing. The findings illuminate an important role for the final step in the CD74-MHC II pathway and a new target for protease inhibitor treatment of B cell diseases.
AuthorsHannes Bergmann, Mehmet Yabas, Alanna Short, Lisa Miosge, Nadine Barthel, Charis E Teh, Carla M Roots, Katherine R Bull, Yogesh Jeelall, Keisuke Horikawa, Belinda Whittle, Bhavani Balakishnan, Geoff Sjollema, Edward M Bertram, Fabienne Mackay, Andrew J Rimmer, Richard J Cornall, Matthew A Field, T Daniel Andrews, Christopher C Goodnow, Anselm Enders
JournalThe Journal of experimental medicine (J Exp Med) Vol. 210 Issue 1 Pg. 31-40 (Jan 14 2013) ISSN: 1540-9538 [Electronic] United States
PMID23267016 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation, B-Lymphocyte
  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • CD8 Antigens
  • Histocompatibility Antigens Class II
  • Membrane Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Fc
  • Tnfrsf13c protein, mouse
  • Tnfsf13b protein, mouse
  • immunoglobulin D receptor
  • invariant chain
  • Bcl2 protein, mouse
  • Aspartic Acid Endopeptidases
  • SPPL2a protein, mouse
Topics
  • Animals
  • Antigens, Differentiation, B-Lymphocyte (metabolism)
  • Aspartic Acid Endopeptidases (genetics, metabolism)
  • B-Cell Activating Factor (genetics, metabolism)
  • B-Cell Activation Factor Receptor (genetics, metabolism)
  • B-Lymphocyte Subsets (immunology)
  • B-Lymphocytes (physiology)
  • CD8 Antigens (genetics, metabolism)
  • Cell Survival
  • Dendritic Cells (physiology)
  • Gene Expression Regulation
  • Histocompatibility Antigens Class II (metabolism)
  • Immunity, Humoral (genetics)
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
  • Receptors, Fc (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: